ValueSet-2.16.840.1.113883.3.464.1003.1162

Sourceus.nlm.vsac#0.11.0:null (v4.0.1)
resourceTypeValueSet
id2.16.840.1.113883.3.464.1003.1162
canonicalhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1162
version20220202
statusactive
publisherNCQA PHEMUR
nameAdultPneumococcalVaccineAdministered
titleAdult Pneumococcal Vaccine Administered
date2022-03-16T01:02:20-04:00
experimentalfalse
Usages(none)

This value set contains 11 concepts

Code System Display
   1119366009 http://snomed.info/sct Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure)
   1119367000 http://snomed.info/sct Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure)
   1119368005 http://snomed.info/sct Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure)
   12866006 http://snomed.info/sct Administration of vaccine product containing only Streptococcus pneumoniae antigen (procedure)
   394678003 http://snomed.info/sct Administration of booster dose of vaccine product containing only Streptococcus pneumoniae antigen (procedure)
   434751000124102 http://snomed.info/sct Pneumococcal conjugate vaccination (procedure)
   871833000 http://snomed.info/sct Subcutaneous injection of pneumococcal vaccine (procedure)
  90670 http://www.ama-assn.org/go/cpt Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use
  90671 http://www.ama-assn.org/go/cpt Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use
  90677 http://www.ama-assn.org/go/cpt Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use
  90732 http://www.ama-assn.org/go/cpt Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use

Produced 08 Sep 2023